A share price of Precigen Inc [PGEN] is currently trading at $1.41, saw in change for the day. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PGEN shares have gain 0.71% over the last week, with a monthly amount drifted -9.32%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, March 2024, Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th. In a post published today on Yahoo Finance, – Inaugural multi-stakeholder event on June 11th (6/11) will raise awareness and bring together individuals living with RRP, caregivers, clinicians, and government officials –.
From an analyst’s perspective:
Precigen Inc [NASDAQ: PGEN] stock has seen the most recent analyst activity on March 22, 2024, when JP Morgan downgraded its rating to a Underweight. On November 18, 2022, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $7 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $13 on February 25, 2021. Wells Fargo initiated its recommendation with a Overweight and recommended $14 as its price target on February 22, 2021. B. Riley Securities started tracking with a Buy rating for this stock on February 18, 2021, and assigned it a price target of $10. In a note dated May 08, 2020, H.C. Wainwright initiated an Buy rating and provided a target price of $5 on this stock.
Precigen Inc experienced fluctuations in its stock price throughout the past year between $0.84 and $1.88. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Precigen Inc [NASDAQ: PGEN] shares were valued at $1.41 at the most recent close of the market. An investor can expect a potential return of 325.53% based on the average PGEN price forecast.
Analyzing the PGEN fundamentals
Trailing Twelve Months sales for Precigen Inc [NASDAQ:PGEN] were 6.22M which represents -30.35% decline. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -3.51%, Pretax Profit Margin comes in at -3.91%, and Net Profit Margin reading is 0.52%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.07 and Total Capital is -0.59. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3567 points at the first support level, and at 1.3033 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4367, and for the 2nd resistance point, it is at 1.4633.
Precigen Inc [PGEN] reported earnings per share of -$0.13 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.08/share, meaning a difference of -$0.05 and a surprise factor of -62.50%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.08 per share as compared to estimates of -$0.08 per share, a difference of $0 representing a surprise of 0.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Precigen Inc [NASDAQ:PGEN] is 2.99. Further, the Quick Ratio stands at 2.99, while the Cash Ratio is 0.33. Considering the valuation of this stock, the price to sales ratio is 56.43, the price to book ratio is 2.96.
Transactions by insiders
Recent insider trading involved KIRK RANDAL J, Director, that happened on Dec 28 ’23 when 96686.0 shares were purchased. Director, KINDLER JEFFREY B completed a deal on Dec 28 ’23 to sell 96686.0 shares. Meanwhile, Director MITCHELL DEAN J bought 25000.0 shares on Sep 22 ’23.
